2000 Fiscal Year Final Research Report Summary
Creation of Transgenic Mice of Dialysis-Related Amyloidosis
| Project/Area Number |
10670990
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Kidney internal medicine
|
|---|
| Research Institution | NIIGATA UNIVERSITY |
|---|
Principal Investigator |
MARUYAMA Hiroki NIIGATA UNIVERSITY, NIIGATA UNIVERSITY MEDICAL HOSPITAL, Assistant, 医学部・附属病院, 助手 (10293218)
|
|---|
| Project Period (FY) |
1998 – 2000
|
| Keywords | transgenic mice / human β_2-microglobulin / CAG promoter / dialysis-related amyloidsis |
|---|
| Research Abstract |
To clarify the pathogenesis and establish therapy of dialysis-related amyloidosis, , we cloned humanβ_2-M cDNA by RT-PCR.We inserted humanβ_2-M cDNA into unique XhoI site of pCAGGS.We generated transgenic mice overexpressing humanβ_2-M (F0 5 lines). We confirmed humanβ_2-MmRNA by RT-PCR and northern blotting analysis, serum and urine humanβ_2-M by western blotting. We generated homozygote transgenic mice by mating F1. Serum humanβ_2-M levels (20-30mg/l)were as high as those levels in hemodialyzed patients. We could not observe dialysis-related amyloidosis in transgenic mice. These results demonstrated that only hyper β_2-M could not cause dialysis-related amyloidosis. We observe dialysis-related amyloidosis patients with chronic renal failure. To add a crucial factor, chronic renal failure, for development of dialysisrelated amyloidosis, we created five-sixths nephrectomized transgenic mice. We will analyze these mice.
|
Research Products
(24 results)
